We examined the effect of imipramine (a tricyclic antidepressant drug) on hydroxyl radical ( Á OH) generation induced by 1-methyl-4phenylpyridinium ion (MPP + ) in extracellular fluid of rat striatum, using a microdialysis technique. Imipramine enhanced the formation of Á OH trapped as 2,3-dihydroxybenzoic acid (DHBA) induced by MPP + (5 mM). Introduction of imipramine (0.1, 0.5 and 1.0 mM) dose-dependently increased the level of dopamine (DA) release. Concomitantly, imipramine enhanced DA efflux and the level of DHBA induced by MPP + , as compared with MPP + -treated control. When corresponding experiments were performed with reserpinized rats, there were small increases in the levels of DA and nonsignificant increase in the formation of DHBA. When iron (II) was administered to imipramine (1 mM)-treated animals, a marked elevation of DHBA was observed, compared with MPP + -only treated animals. A positive linear correlation was observed between iron (II) and DHBA (R 2 = 0.985) in the dialysate. These results indicate that imipramine enhances generation of Á OH induced by MPP + during enhanced DA overflow.
Introduction
Various antidepressant drugs have been developed and their antidepressive effects have been observed in animal model [1] . It has been demonstrated that tricyclic antidepressant drugs inhibit monoamine oxidase (MAO; EC 1.4.3.4) in vitro [2] [3] [4] . MAO exists in two forms, form A (MAO-A) and form B (MAO-B), based on its substrate specificity and sensitivity to inhibitors [5, 6] . MAO-A preferentially deaminates 5-hydroxytryptamine (5-HT), whereas MAO-B deaminates h-phenylethylamine (h-PEA). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces a parkinsonian syndrome after its conversion to 1methyl-4-phenylpyridinium ion (MPP + ) by MAO-B in the brain [7, 8] . It has been shown that MAO-A is the major enzyme responsible for the deamination of dopamine (DA) in the rat striatum [9] . Although there are many papers showing that DA autoxidation and oxidative stress may be involved in Parkinson's disease [10 -12] , the etiology of Parkinson's disease still remains obscure.
Autoxidation and MAO-dependent oxidation of DA can lead to the formation of reactive cytotoxic free radicals whose generation could be influenced by the antidepressants because these antidepressants could inhibit catecholamine uptake and MAO activities. We as well as others reported that MPP + induces a massive release of DA in the striatum, which leads to increased free radicals [11, 13, 14] . In dopaminergic nerve cells, free radicals are mainly generated by MAO via deamination of DA and nonenzymatically by the autoxidation of DA [15] . The present study focuses on the effect of imipramine (tricyclic antidepressant drug) on hydroxyl radical ( Á OH) generation induced by MPP + in rat striatum.
Materials and methods

Animals
Adult female Wistar rats weighing 300 -400 g were kept in an environmentally controlled room (20 -23 jC, 50-60% humidity, illuminated from 07:00 to 19:00) and fed food and water ad libitum. At the end of the experiments the rats were sacrificed using an overdose of anesthetic. All procedures in dealing with the experimental animals met the guideline principles stipulated by the Physiological Society of Japan and the Animal Ethics Committee of the Oita Medical University.
Chemicals
Imipramine hydrochloride was purchased from Ciba-Geigy (Takarazuka, Japan). MPP + was purchased from Research Biochemicals Inc., MA, USA. Sodium salicylate and its hydroxylated metabolites were purchased from Sigma Chemical Co. (St. Louis, MO, USA). All other chemicals were obtained from Wako Pure Chemical Industries (Osaka, Japan). The two radiochemical substrates used in this study, 5-hydroxytryptamine binoxalate ([2-14 C]-5-HT; 1.48-2.22 Gbq/mmol) and h-phenylethylamine hydrochloride ([ethyl-1-14 C]-h-PEA, 1.48 -2.22 Gbq/mmol), were purchased from Dupont NEN (New England Nuclear) Products (Boston, MA, USA). In the case of reserpinized rats, reserpine (5 mg/kg; Daiichi Pharmaceutical, Japan) was injected intravenously into the rats 24 h before the experiments.
Experimental protocol
Assay of MAO activity
The rats were killed by decapitation and the brains were quickly removed and homogenated in 10 ml of 10 mM phosphate buffer, pH 7.4, containing 0.32 mM sucrose solution. To examine the effects of imipramine on MAO activity in vitro, the enzyme was preincubated for 20 min at 25 jC with imipramine (0.001 to 1.0 mM) before adding the substrates. Final concentrations of substrate (5-HT for MAO-A, and h-PEA for MAO-B) were 100 and 10 AM, respectively. The remaining MAO activity was measured by adding 20 Al of substrate solution and the mixture was incubated for 20 min at 37 jC. The reaction was stopped by adding 2 N HCl (200 Al). The reaction products were extracted with ethyl acetate -benzene mixture (1:1, v/v) saturated with water, and the radioactivity in the extract was measured using Beckmann LS-9000 scintillation counter. The protein concentrations of the enzyme preparations were measured according to the method of Lowry et al. [16] using bovine serum albumin as a standard. The data were corrected using protein concentration, and expressed as percent, compared to control (100%). One hundred percent of MAO-A and -B activities were 0.072 F 0.03 and 1.02 F 0.05 nmol/min/mg protein, respectively.
Microdialysis experiments
The rats were anaesthetized with chloral hydrate (400 mg/kg, i.p.), and the level of anaesthesia was maintained by intraperitoneal injection of chloral hydrate (20 mg/kg).
Ringer's solution containing 147 mM NaCl, 2.3 mM CaCl2 and 4 mM KCl, pH 7.0, was used for perfusion (1 Al/min) through a microdialysis probe into the striatum. The recovery rate of 0.1 AM DA was 20.8 F 0.9% at flow rate of 1 Al/ min. The microdialysis probe was pre-washed with Ringer's solution for at least 30 min prior to stereotaxical implantation in the striatum (stereotaxic coordinates: AP: 1.0, R/L: 2.5, H: À 7 mm from dura matter) [17] . Thereafter, sodium salicylate in Ringer's solution (0.5 nmol/Al/min) was perfused by a microinjection pump (Carnegie Medicine CMA/ 100, Stockholm, Sweden) to trap Á OH radicals [18, 19] in the striatum, and basal levels of dihydroxybenzoic acid (DHBA) were determined during a definite period. Brain dialysate (1 Al/min) was collected every 15 min in small tubes containing 15 Al of 0.1 N HClO 4 to prevent amine oxidation and assayed immediately for DHBA by highperformance liquid chromatography with electrochemical (HPLC-EC) procedure [18 -20] . The dialysate samples were promptly injected into an HPLC-EC system equipped with a glassy carbon working electrode (Eicom, Kyoto, Japan) and an analytic reverse-phase column on an Eicompak MA-5ODS column (5 Am, 4.6 F 150 mm; Eicom). The working electrode was set at a detection potential of 0.75 V.
Statistical analysis
All values are presented as means F S.E. The significance of difference was determined by using ANOVA with Fisher's post-hoc test. A P value of less than 0.05 was regarded as being statistically significant.
Results
Effect of imipramine on MAO activity in vitro
To determine the mechanism by which MAO activity was inhibited by imipramine, the effects of various concen- trations of imipramine on MAO in rat brain homogenates were studied in vitro using 5-HT and h-PEA as substrates. Imipramine (0.001, 0.01, 0.1 and 1 mM) inhibited both MAO-A and -B activities in a dose-dependent manner. When the brain homogenates were preincubated at 25 jC for 20 min with imipramine, the residual activity of MAO-A and MAO-B activities with 100 AM imipramine were 63% and 4%, respectively ( Fig. 1 ). However, 1 mM imipramine completely inhibited both MAO activities. observed (Fig. 3B ). As shown in Fig. 4 , imipramine (0.01, 0.1 and 1.0 mM) dose-dependently increased the level of DA release. At 1 mM of imipramine, the increase in DA was statistically significant ( P < 0.05, n = 5). To confirm whether the Á OH generation was based on a Fenton-type reaction, iron (II) was infused through the dialysis probe. When iron (II) (2, 5 and 10 AM) was administered to MPP + -pretreated animals, iron (II) clearly produced a dose-dependent increase in the levels of DHBA, showing a positive linear correlation between iron (II) and Á OH formation trapped as DHBA (R 2 = 0.985) in the dialysate, as compared with the iron (II)-only treated group (Fig. 5 ). The data suggest that the effect of imipramine on Á OH formation was based on the Fenton-type reaction.
Discussion
We have demonstrated that imipramine (a tricyclic antidepressant drug) enhances generation of Á OH induced by MPP + in the extracellular space of the striatum. It is known that tricyclic antidepressant drugs inhibited MAO activities and that, in vitro, these drugs are more potent inhibitors of MAO-B than MAO-A [3, 4] . MAO is a brain enzyme that plays a role in the metabolism of various catecholamine. Both MAO-A and MAO-B activities in rat brain were inhibited by imipramine ( Fig. 1) . Kato et al. [21] reported that MAO inhibitor caused the accumulation of DA in the extracellular fluid. We previously reported [3] that the level of the oxidized DA metabolite DOPAC decreased following the administration of imipramine. This result indicates that imipramine increased the level of DA. MAO is one of the enzymes metabolizing various neurotransmitter monoamines [14] . If MPP + or its related compound(s) is responsible for inducing Parkinson disease, inhibition of MAO-B may lead to induce protective effect against Á OH formation [22] . It was reported that the MAO-B inhibitors can diminish neuronal cell death [23] . In rat brain, MPP + is a more potent MAO-A inhibitor than MAO-B [24] , and MAO-A is predominantly responsible for striatal DA oxidation [21] . On the contrary, in human brain, MAO-B is responsible for DA oxidation [25, 26] . The DA that accumulates in the extracellular fluid following administration of antidepressants can undergo autoxidation, which in turn leads (possibly by an indirect mechanism) to the formation of cytotoxic Á OH free radicals. As shown in the present study, the antidepressant inhibited MAO activities in vitro. Antidepressant drugs have heretofore been considered effective in the treatment of depression because they inhibit the active uptake of amines in the presynaptic cells of the brain [27, 28] . Imipramine is also potent inhibitors of DA reuptake. Regardless of their specific mechanisms of action, the consequence is increased extracellular levels of DA. This may explain the observed increase in Á OH. Both nonenzymatic and enzymatic mechanisms may contribute to free radical formation induced by antidepressant drugs in the striatum in vivo.
The concentration profile of the administered compounds in the surrounding interstitial space is unknown: in general, the extracellular concentration of a compound given through the probe would never reach the concentration in the dialysis probe. This is an unavoidable limitation of the microdialysis technique that should be kept in mind when interpreting the experimental data. Introduction of imipramine (1 mM) drastically increased the DA efflux and the level of DHBA induced by MPP + (Fig. 2) . Although there are many reports about the effect of MPP + on Á OH generation, the mechanism of Á OH generation by MPP + is obscure. Free radical formation enhanced by MPP + in the striatum appeared to be dose-dependent and positively correlated with amounts of sustained DA overflow [13] . DA is known to be autoxidated in the presence of oxygen and transition metal [12, 29] . When imipramine concentration in the perfusate was increased, DA efflux was enhanced with concomitant increase in Á OH formation. Our obtained data demonstrated that sustained DA overflow elicited by imipramine in the striatum also led to enhanced MPP +induced Á OH formation. These data are consistent with the notion that DA autoxidation and sustained DA turnover can lead to free radical formation, which in turn causes oxidative damage in the iron-enriched nigral neuron during senescence and Parkinson's diseases [12, 13] . This evoked DA overflow was enhanced by imipramine. The levels of DA and DHBA in reserpinized rats were drastically reduced, as compared with that of imipramine and MPP + -treated groups (Fig. 3) . The results also suggest that the mechanism of imipramine and MPP + -induced Á OH formation was via DA efflux. The present study demonstrated that imipramine increased Á OH formation in the extracellular space of the striatum with concomitant DA release. Therefore, imipramine increased the Á OH formation trapped as DHBA. Moreover, to confirm whether the imipramine-evoked Á OH generation in the MPP + -treated rats was based on the Fenton-type reaction, the DHBA formation was measured in the presence of iron in imipramine-and MPP + -treated rats. Iron (II) clearly produced a dose-dependent increase in the levels of DHBA (Fig. 5 ). This finding indicates that extracellular DA is needed for the observed effect of Fenton-type reaction.
MPP + causes a sustained DA release into extraneuronal space, generating oxygen free radicals with extracellular DA autoxidation [11] . This could lead to the formation of Á OH radicals, which may induce lipid peroxidation, protein crosslinking and DNA damage, mediated by base pair mutation [30] . If toxic species are being produced on Parkinson's disease, they would normally be inactivated by a variety of protective mechanisms, but the mechanisms, however, may be impaired in the substantia nigra of patients with Parkinson's disease; reduced levels of, e.g., catalase and glutathione (GSH) [31] . The enzyme MAO is one of the enzymes metabolizing various neurotransmitter monoamines [14] . Among MAO-B inhibitors, L-deprenyl is widely used for the treatment of patients with Parkinson's disease. Inhibition of MAO-B may be involved in its protective effect [22] , if MPP + or related compound(s) is responsible for inducing Parkinson's disease. It is clear that MAO-B is responsible for the production of MPP + . Therefore, the MAO-B inhibitors can diminish neuronal cell death [23] .
DA is known to be autoxidized in the presence of oxygen and iron (II), and to be converted to semiquinone, quinone, zwitteric 5,6-dihydroxyindoles and melanin [11] . The DA efflux was enhanced imipramine and MPP + administration. DA is known to undergo autoxidation in the presence of oxygen and iron (II) [13, 29] . Normally, iron (III) is bound to endogenous chelators such as ADP and, in the absence of a significant amount of ferritin in the substantia nigra, could be chelated by melanin. Increased concentrations of DA could serve as the catalyst for the conversion of iron (III) to iron (II) by melanin and, in the presence of H 2 O 2 , results in further formation of Á OH, depending on the environmental conditions [32] . The production of Á OH in the presence of melanin is significantly greater when iron (III) is predominant [32] , and is further demonstrated by the greater lipid peroxidation of rat cerebral cortex in the presence of iron (II) and higher DA melanin concentrations [33] . An enhanced generation of cytotoxic Á OH radicals through DA accumulation could accelerate the MPP + -induced degeneration of nigral neurons. Accordingly, imipramine enhances generation of Á OH induced by MPP + during enhanced DA overflow.
In conclusion, a tricyclic antidepressant drug may play a key role in Á OH formation by the release of DA from nigrostriatal nerves in the brain by the action of MPP + .
The results in the experiment may be useful for elucidating the actual mechanism of free radical formation in the patho-genesis of neurodegenerative brain disorders including Parkinson's disease, Alzheimer's disease and traumatic brain injuries.
